Ameritas Investment Partners, Inc. Vera Therapeutics, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q4 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 4,639 shares of VERA stock, worth $133,695. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,639
Previous 4,000
15.98%
Holding current value
$133,695
Previous $176,000
11.36%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$162 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$126 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$96.2 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$85.3 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$85 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $779M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...